Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Daniela, Rotondi"'
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background In adult population, Growth Hormone Deficiency (GHD) is a complex clinical condition with heterogeneity of causes and duration. Growth Hormone (GH) replacement therapy has beneficial effects entailing a chronic and expensive use.
Externí odkaz:
https://doaj.org/article/1262167775e4460d919ae340b74780ba
Autor:
Gianluca Tornese, Flavia Pricci, Maria Chiara Pellegrin, Marika Villa, Daniela Rotondi, Elvira Agazio, Egidio Barbi
Publikováno v:
Italian Journal of Pediatrics, Vol 45, Iss 1, Pp 1-5 (2019)
Abstract Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1800. The latest data from the N
Externí odkaz:
https://doaj.org/article/f9dbc813e2344980bbc63f82b464def5
Autor:
Barbara Brunetto, Sonia Brescianini, Bianca Barletta, Cinzia Butteroni, Daniela Rotondi, Rosalba Masciulli, Malaguti Aliberti, Carlo Pini, Gabriella Di Felice, Patrizia Iacovacci
Publikováno v:
Annali dell'Istituto Superiore di Sanità, Vol 45, Iss 4, Pp 415-422 (2009)
Exposure to indoor allergens is an important risk factor for sensitisation and respiratory allergy. The aim of this paper was to evaluate the levels of mite, cat and latex allergens in dust collected from an indoor workplace and to assess whether the
Externí odkaz:
https://doaj.org/article/5c01c2819a5f46cbb7f08133b6b9e047
Autor:
Augusto Alberto Pastorelli, Roberto Da Cas, Daniela Rotondi, Emanuela Medda, Simona De Angelis, Antonella Olivieri, Osservatori Regionali per la Prevenzione del Gozzo, Paolo Stacchini, Centri Regionali e inter-Regionali per lo Screening Neonatale dell’Ipotiroidismo Congenito
Publikováno v:
L'Endocrinologo. 20:245-248
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::878893f2f9758b17fe745b4828e49ca7
https://doi.org/10.1007/s40619-019-00596-z
https://doi.org/10.1007/s40619-019-00596-z
Autor:
Simona, De Angelis, Daniela, Rotondi, Enzo, Gilardi, Paolo, Stacchini, Augusto, Pastorelli, Angela, Sorbo, Marilena, D'Amato, Anna Chiara, Turco, Emanuela, Medda, Roberto, Da Cas, Daniela, Agrimi, Sebastiano, Andò, Daniela, Bonofiglio, Francesco, Boi, Giulio, Doveri, Maurizio, Gasperi, Pietro, Lanzetta, Domenico, Meringolo, Caterina, Mian, Giorgio, Napolitano, Fabio, Orlandi, Efisio, Puxeddu, Giorgio, Radetti, Concetto, Regalbuto, Mariacarla, Moleti, Augusto, Taccaliti, Maria Laura, Tanda, Massimo, Tonacchera, Ulisse, Salvatore, Carlo, Corbetta, Renzo, Ciatti, Vera, Stoppioni, Nicola, Perrotti, Onorina, Marasco, Giovanna, Scozzafava, Marta, Camilot, Francesca, Teofili, Francesca, Righetti, Antonio, Dimida, Antonella, Olivieri.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3686::aa00842eeaf2375272853bd246487d90
http://hdl.handle.net/11573/1554464
http://hdl.handle.net/11573/1554464
Autor:
Maria Cristina Vigone, Daniela Rotondi, Giovanna Weber, Graziano Barera, Silvana Caiulo, Tiziana de Filippis, Marianna Di Frenna, Maria Grazia Patricelli, Luca Persani, Olivieri A, Carlo Corbetta, Emanuela Medda, Gaia Vincenzi, Simona De Angelis
Publikováno v:
The Journal of clinical endocrinology and metabolism. 106(1)
Context Analysis of a 2-screen program for congenital hypothyroidism (CH) was performed using differential dried-blood spot thyrotropin (bTSH) cutoffs of 10 mU/L at first screening (all infants) and 5 mU/L at second screening (selected infants). Obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01d2241cd6348f5aad191eedcb4af64
https://pubmed.ncbi.nlm.nih.gov/33274373
https://pubmed.ncbi.nlm.nih.gov/33274373
Autor:
Marcello Bagnasco, Caterina Di Cosmo, Antonio Dimida, Concetto Regalbuto, Daniela Rotondi, Elena Nazzari, Irene Bossert, Massimo Tonacchera, Teresa Rago, Mariacarla Moleti, Emanuela Medda, Antonella Olivieri, Giacomo Carlo Sturniolo, Graziano Cesaretti, Francesco Vermiglio, Simona De Angelis, Mara Schiavo
Background: The frequency of overweight (OW) and obese (OB) children has increased worldwide, particularly in economically developed countries. No studies have been conducted to verify whether the ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e58934c3e9f655af10ff34820d44b0
http://hdl.handle.net/11570/3187750
http://hdl.handle.net/11570/3187750
Autor:
Daniela Rotondi, Paolo Roazzi, Elvira Agazio, Marika Villa, P Panei, Flavia Pricci, Fabio Maccari
Publikováno v:
Journal of Endocrinological Investigation
Background In Italy, the utilization and the reimbursement of Growth Hormone (rGH) therapy by the National Health System (Servizio Sanitario Nazionale) are regulated by the “Note #39” included in the “Notes for the use of drugs” by the Italia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0363999742e6fa5176f5ccfd8d6ab5
https://doi.org/10.1007/s40618-018-0980-3
https://doi.org/10.1007/s40618-018-0980-3
Autor:
Rossella Gelsomino, Marianna Di Frenna, Rita Ortolano, Maria Cristina Vigone, Olivieri A, Pietro Costa, Francesca Calaciura, Emanuela Medda, Marco Gabbianelli, Monica Bartolucci, Tiziana de Filippis, Alessandra Cassio, Giovanna Weber, Simona De Angelis, Daniela Rotondi, Silvana Caiulo, Giulia Gelmini, Luca Persani
ContextNewborn screening program for congenital hypothyroidism (CH) adopting rescreening in at-risk neonates.ObjectivesTo estimate the concordance rate for CH in twin pairs discordant at the first screening; to verify whether long-term follow-up of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51d02c600ba747168e6275a571a92cc
Autor:
Daniela Rotondi, Elvira Agazio, Maria Chiara Pellegrin, Marika Villa, Flavia Pricci, Egidio Barbi, Gianluca Tornese
Publikováno v:
Italian Journal of Pediatrics
Italian Journal of Pediatrics, Vol 45, Iss 1, Pp 1-5 (2019)
Italian Journal of Pediatrics, Vol 45, Iss 1, Pp 1-5 (2019)
Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1800. The latest data from the National R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec8292870f4ac4c8fe84f8054a89c4c
https://ijponline.biomedcentral.com/articles/10.1186/s13052-019-0715-x
https://ijponline.biomedcentral.com/articles/10.1186/s13052-019-0715-x